The DES Center

Filter Your Results




FDA Seeks to Strengthen Public Warnings and Recall Notifications; CDRH Outlines Strategic Priorities

January 18, 2018 -- US Food and Drug Administration (FDA) Commissioner Scott Gottlieb, MD, issued a statement on the agency's new policy steps for strengthening public war…

First United States Commercial Implantations With EluNIR DES Performed

January 11, 2018 -- Cordis, a Cardinal Health company, and Medinol announced that the first commercial cases using the EluNIR drug-eluting stent (DES) in the United States wer…

Five-Year DESSOLVE Data Published for Micell's MiStent

January 9, 2018 -- Micell Technologies, Inc. announced that a report of the 5-year data from the DESSOLVE I and DESSOLVE II trials by Professor William Wijn, MD, et al has bee…

Final 5-Year SORT OUT V Outcomes Published for Terumo's Biodegradable Nobori DES

December 21, 2017 -- Online in EuroIntervention, Lars Jakobsen, MD, et al reported the long-term safety and efficacy of the biodegra

Five-Year PLATINUM Results Published for Boston Scientific's Promus Element EES

December 18, 2017 -- Five-year results from the multicenter, randomized PLATINUM trial were published by Christopher R. Kelly, MD, et al in Journal of the American College of …

Analysis of ABSORB Trials Evaluates Effect of Technique on Outcomes After BVS Implantation

December 11, 2017 -- An analysis of the effect of technique on outcomes after bioresorbable vascular scaffold (BVS) implantation in the ABSORB trials was published by Gregg W.…

Twelve-Month Results Published From DESSOLVE III Trial of Micell's MiStent

December 6, 2017 -- Micell Technologies, Inc. announced that 12-month results from the DESSOLVE III clinical trial of the company's MiStent, a sirolimus-eluting bioabsorba…

Cordis and Medinol Announce FDA Approval of the EluNIR DES

November 30, 2017 -- Cordis, a Cardinal Health company, and Medinol USA announced US Food and Drug Administration approval of the EluNIR drug-eluting stent (DES) for the treat…




Contact Info

For advertising rates and opportunities, contact:
Craig McChesney

Stephen Hoerst

Charles Philip

About Cardiac Interventions Today

Cardiac Interventions Today (ISSN 2572-5955 print and ISSN 2572-5963 online) is a publication dedicated to providing comprehensive coverage of the latest developments in technology, techniques, clinical studies, and regulatory and reimbursement issues in the field of coronary and cardiac interventions. Cardiac Interventions Today premiered in March 2007 and each edition contains a variety of topics in a flexible format, including articles covering various perspectives on current clinical topics, in-depth interviews with expert physicians, overviews of available technologies, industry news, and insights into the issues affecting today's interventional cardiology practices.